Training Programs Accordions

Director:
Gilbert C. White, II, MD

Contact:
Attn: Portlynne Joseph/T32 Postdoc
Blood Research Institute
PO Box 2178
Milwaukee, WI 53201-2178
Email: postdoc@bcw.edu
Website: https://www.bcw.edu/bcw/Research/T32Fellowship/index.htm

Program Scope and Mission – Research opportunities available to trainees cover a broad range of basic and clinical research subjects relevant to transfusion medicine and hematology; including; Immunology, Vascular Biology/Hemostasis, Transfusion Medicine, Stem Cell Biology, and Clinical Research. The research training experience will be essentially full time. Trainees will be expected to gain a basic understanding of the disciplines in which they undertake their investigations, develop competency with a variety of research technologies, strengthen their grasp of their chosen research by taking selected courses in the graduate studies program of Medical College of Wisconsin, and develop the ability to conduct independent research. Time spent in fellowship training is regarded as one of several stages of professional development. Accordingly, additional tracks will be offered to selected trainees including; the opportunity 1) to apply for a Clinical Investigator Development Award (K08) for continued mentoring, 2) to apply for independent grant support, and 3) for those oriented toward a career in transfusion medicine, an opportunity for further training as a junior member of BloodCenter's medical staff. Ultimately, trainees are expected to pursue academic or alternate careers in transfusion medicine, hematology, or closely related fields.

Director:
Karin Hoffmeister, M.D.
Senior Investigator Blood Research Institute
Professor of Biochemistry at Medical College of Wisconsin
Associate Professor of Pediatrics, Harvard Medical School
Email: K12Admin@bcw.edu

Contact:
Christina Daniels
K12 Program Administrator
BloodCenter of Wisconsin
Blood Research Institute
8733 W. Watertown Plank Rd.
Wauwatosa, WI 53226
Phone: (414) 937-6896
Email: Christina.Daniels@BCW.EDU
Website: https://www.translationalglycomics.com

Program Scope and Mission – Translational medicine fosters cross-functional collaborations between researchers and clinicians to facilitate new and precision-driven treatments for individualized therapy. While scientists and clinicians successfully applied this approach to four fundamental building blocks of life (nucleic acids, lipids, proteins and carbohydrates), the science of glycans (carbohydrates) has received the least attention. The diverse functions of glycans contribute to the structural integrity of biomolecules, extracellular matrix formation, signal transduction, protein folding, information exchange between cells, and host-pathogen interactions. Despite their functional diversity and specificity, carbohydrates are commonly associated with weight gain and diabetes while their major contributions to health and disease remain vastly understudied. Furthermore, the use and modulation of glycans has been largely unexplored in therapeutic strategies. There is an urgent need to support and educate glycoscientists concomitantly with the biology of human health and disease, thus enabling clinicians and glycoscientists to recognize medical needs and therapeutic opportunities. To meet these needs, the National Heart, Lung, and Blood Institute (NHLBI) for the first time has offered a K12 Career Development Program in translational glycosciences titled “National Career Development Consortium for Excellence in Glycosciences.”

One of the four national sites is the Blood Research Institute and the Center for Translational Glycomics, BloodCenter of Wisconsin (BCW), in association with the Medical College of Wisconsin (MCW), Roswell Park Comprehensive Cancer Center (Roswell), and Virginia Commonwealth University (VCU). This program, The Medical and Translational GlycOmics Program (Translational GlycO Program), is a multi-institution (Wisconsin, New York and Virginia) program, linking unique and diverse glycoscience expertise with research facilities, major teaching hospitals, blood banking and pharmaceutical education. It is expected that the Translational GlycO Scholars will commit to and pursue a glycoscience based investigation, as it relates to the mission of the NHLBI (heart, blood, lung, and sleep disorders). Training in investigative glycoscience thought processes and experimental tools will be provided through a rigorous program involving hands-on research, didactic coursework, collaboration with experienced scientists in and outside the field, dissemination of knowledge, paper and grant writing activities, and participation in the national K12 consortium. Scholars will become knowledgeable in 1) molecular aspects of glycoscience; 2) experimental research inquiries into functions of glycans; 3) translation of bench research to the bedside; 4) dissemination of research to scientists and the lay public; and 4) writing extramurally funded grant applications. For more information and application processes refer to the K12 Program Website

Director:
Ivor Benjamin, M.D., F.A.H.A., F.A.C.C.
Director, Cardiovascular Center
Professor, Department of Medicine
Froedtert & Medical College of Wisconsin
Email: ibenjamin@mcw.edu
https://www.mcw.edu/Cardiovascular-Center/Research-Labs/Ivor-Benjamin-MD-FAHA-FACC.htm

Contact:
MCW Cardiovascular Center
Medical College of Wisconsin
8701 Watertown Plank Rd.
Milwaukee, WI 53226
(414) 955-5611 | Fax (414) 456-6515
Email: cvc@mcw.edu
Website: https://www.mcw.edu/departments/cardiovascular-center-heart

Program Scope and Mission –

This five year T32 program is one of only six post-doctoral T32 training programs on the Milwaukee Medical Regional Campus. The grant provides up to three-years of training for post-doctoral fellows with an MD, PhD, PharmD, or DO degree (two new slots/year). Forty-six basic scientists and translational investigators serve as mentors in a program that is supported by specific research areas of scientific excellence (“Signature Programs”), a highly-integrated collaborative research environment, and access to an extensive research infrastructure.

This three-year training commitment emphasizes critical components designed to launch/sustain research careers: • Individualized development plans (IDPs), • Personalized multidisciplinary mentoring teams, • Training in core competencies, and • Industry/biotechnology or scientific liaison career options for trainees not pursuing a traditional career in academia. Overall, the ultimate goal of this training program is to train the next generation of cardiovascular scientists, including underrepresented minorities, by incorporating broad-based, personalized, supportive, and rigorous training opportunities. Additional support for trainees is provided by a grant from the A. O. Smith Foundation for the Cardiovascular Center’s A. O. Smith Fellowship Scholars Program. This unique program is designed to support talented cardiovascular researchers and physicians in an innovative educational program that aims to provide mentoring, training, research support, and the necessary resources to overcome the barriers that exist to launching and sustaining a successful research career.

Director:
Mark K. Eskandari, MD, F.A.C.S.
The James S. T. Yao, MD, PhD, Professor of Vascular Surgery
Chief and Program Director, Division of Vascular Surgery
Northwestern University
Feinberg School of Medicine
676 N. St. Clair, #650
Chicago, IL 60611

Contact:
Marsha Blunt, VSSTP Program Coordinator
Telephone: (312) 926-7775
Northwestern Email: marsha.blunt@nm.org
https://www.surgery.northwestern.edu/divisions/vascular/research/scientist-training.html

Program Scope and Mission –

The NIH-funded Vascular Surgery Scientist Training Program at Northwestern University is a two-year mentored research training program designed for surgical residents (MD/DO) in general, cardiac, and vascular surgery interested in vascular biology or vascular biomedical engineering careers. Our goal is to provide a seamless multidisciplinary environment in which the trainee may interact with a diverse group of distinguished research faculty. The T32 mechanism provides a stipend, tuition, fees for coursework, travel funds, and health insurance.

The key to this program is an individualized training plan developed by the mentor and trainee. The unique multidisciplinary environment provides trainees with opportunities to work with mentors from different disciplines. The goal of this program is to match the research interest of the trainee to mentors, coursework, seminars, meetings, and a research plan that will collectively provide the experience necessary to launch a successful career as a physician scientist. Trainees may select one of several tracks of study or a combination of tracks:

• Vascular biology with a basic science or translational emphasis,
• Clinical outcomes/health services research
• Biomedical devices in partnership with the Biomedical Engineering Department
• An integrated program designed by the trainee and his/her mentors.

Trainees who select the clinical outcomes/health services research track will pursue the Master of Science in Health Services and Outcomes Research degree program at NU.

Candidates must hold either an MD or DO degree and must have completed at least two years of clinical training prior to enrolling in the program. Candidates must be U.S. citizens, noncitizen nationals, or have been lawfully admitted for permanent residence at the time of appointment. Minorities and women are encouraged to apply. Applicants will submit a written application along with three letters of recommendation.

Director:
Dr. Vidu Garg
Vidu.Garg@nationwidechildrens.org
and
Dr. Peter Mohler

Contact:
Dr. Brenda Lilly
Brenda.Lilly@nationwidechildrens.org
and
Dr. Vidu Garg
Vidu.Garg@nationwidechildrens.org

Program Scope and Mission – A postdoctoral fellow position is available for the T32 Fellowship Program entitled, “Training in Congenital and Acquired Heart Disease.” The program is jointly hosted by the Research Institute at Nationwide Children’s Hospital and the Dorothy M. Davis Heart and Lung Research Institute at The Ohio State University (PIs: Dr. Vidu Garg and Dr. Peter Mohler).

Eligibility requirements are as follows:
• MD, PhD, MD/PhD, DO, DVM, or PharmD, particularly underrepresented minorities, are encouraged to apply. Applicants will receive stipend (at appropriate NIH stipend guidelines), benefits and tuition support.
• Applicant must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence at the time of appointment.
• Proposed research must be directly related to aspects of congenital or acquired cardiovascular disease and can be basic, translational, clinical or outcomes research.
• 1 year fellowship that is renewed based upon productivity (for a maximum of 2 years).
• Applicants are required to participate in the T32-developed curriculum (i.e. didactic coursework, seminars and/or journal clubs).
• Applications are scored in 3 areas: trainee qualifications, scientific merit and training potential.

Website: https://omrf.org/programs/cardiovascular-biology-research-program/

The Oklahoma Medical Research Foundation (OMRF) is an independent, nonprofit biomedical research institute dedicated to understanding and developing more effective treatments for human diseases. It is adjacent to the University of Oklahoma Health Sciences Center (OUHSC) in downtown Oklahoma City.

Vascular Research at OMRF: OMRF’s Cardiovascular Biology Research Program investigates fundamental mechanisms involved in cardiovascular and lymphatic development and function, blood coagulation, fibrosis, inflammation, and sepsis. Our scientists integrate their expertise in genetics, biochemistry, molecular biology and physiology in their research. The program houses 11 independent laboratories, which are home to an interactive community of scientists at various career stages. Our labs have exciting training opportunities for motivated graduate students and postdoctoral researchers. Our trainees benefit from OMRF’s outstanding shared resources and collaborative environment, including a vibrant institutional training program for postdoctoral researchers. OMRF is consistently voted a top place to work in Oklahoma and the U.S.

Graduate Student Training: Interested candidates are eligible to pursue research opportunities in our labs after enrolling at the University of Oklahoma Health Sciences Center (OUHSC). The university has graduate training programs for Ph.D., M.S., and M.D./Ph.D. students.

Postdoctoral Training: Qualified candidates can contact the principal investigators in our program to enquire about availability of positions in their labs. Please include a cover letter, CV, and career goals.

Director:
James K. Liao, MD
Harold H. Hines Professor, Committee on Molecular Metabolism and Nutrition
Chief, Department of Medicine – Section of Cardiology
Director, Physician Scientist Development Program
Email: jliao@medicine.bsd.uchicago.edu
https://biomedsciences.uchicago.edu/page/james-liao-md

Contact:
Phetcharat Chen, Administrator
Email: pongusaha@medicine.bsd.uchicago.edu
Website:https://biosciences.uchicago.edu/directory/cardiovascular-sciences-training-grant-t32-hl007381

Program Scope and Mission – The Cardiovascular Training Grant supports both post-doctoral (M.D. and Ph.D.) and pre-doctoral (Ph.D.) students for terms of 2-3 years to work in the laboratories of one of 33 trainers, whose research is in the cardiovascular sciences. The trainers include faculty from Cardiology, Pathology, Internal Medicine, Neurology, Pharmacology and Physiology, and Biochemistry and Molecular Biology. The program emphasizes training in vascular biology, atherosclerosis, cardiac development, cellular electrophysiology, cellular metabolism, cell signaling, gene regulation, and genetic disease.

Director and Contact:
Jeffery D Molkentin, PHD
Children's Hospital Medical Center-Cincinnati
Office of Sponsored Programs
3333 Burnet Avenue, MLC #7030
Cincinnati, OH 45229
Phone: 513-636-3557
Jeff.molkentin@cchmc.org
https://www.cincinnatichildrens.org/research/divisions/m/mcb/labs/molkentin

Program Scope and Mission – The University of Cincinnati and Children’s Hospital is carrying on a proud tradition of excellence in cardiovascular research and mentorship, which began 35 years ago under Dr Arnold Schwartz as one of the longest training programs in cardiovascular. Our current collective 19 faculty has placed 297 of their past trainees into academics over their careers, 154 of whom have run, or currently run independent research programs. The overall scientific emphasis of our training program will continue to build from a basic platform of cardiovascular physiology, cell biology, biochemistry and pharmacology, but will also incorporate the latest approaches in the post genomic era, as well as incorporating clinical and translational approaches. The cardiovascular environment at Cincinnati Children's and the University of Cincinnati is considered one of the very best in the country, with 19 NIH funded faculty (some 49 NIH grants amongst them as PI status), 166 collaborative papers published in 10 years, and the very latest technologies and approaches with outstanding core support. The leadership consists of the co-PIs Drs. Evangelia Kranias and Jeffery D. Molkentin, both of whom have a long standing track record of working closely together (15 years), as well as having excellent mentorship credentials. The training grant funds 3 pre- and 3 postdoctoral trainees. Predocs are selected by the Internal Advisory Committee from a wide pool arising from departmental graduate programs, while postdoctoral candidates are selected based on being accepted into a mentor's laboratory and then passing the screening process by the Internal Advisory Committee and co-PIs. The training program also has an educational core where both pre-docs and post-docs take elective classes in cardiovascular biology, genetics, statistics, grant writing and ethics in research. More importantly, the cardiovascular training faculty at the University of Cincinnati and Children’s Hospital is one of the largest groups in the nation and they incorporate the very latest technologies in the pursuit of their scientific endeavors. Strengths include generation of transgenic and gene-targeted mice, as well as CRISPR-mediated mouse production, in the pursuit of understanding single gene function in complex cardiovascular diseases. Genetics are also employed and the program also has a strong clinical mentorship track for trainees interested in translational science.

mporary and a defined period (2-year) of mentored advanced training and professional development following completion of a doctoral degree program.

PI/Program Director:
Asrar B. Malik PhD

Contact:
Dr. Asrar B. Malik
Director of Center for Lung and Vascular Biology
University of Illinois College of Medicine
Department of Pharmacology
835 South Wolcott Ave, E403 MSB
Chicago, IL 60612
Phone: 312 996-5672
Email: abmalik@uic.edu
http://mcph.uic.edu/lungt32/

Program Scope and Mission – The NIH-funded UIC vascular biology training program is currently in its 25th year, providing comprehensive and cutting-edge training in vascular biology. Research topics include mechanisms of vascular regeneration, the use of stem cell therapies in vascular disease, the critical role of the vasculature in inflammation and immunity, modeling inherited vascular diseases with induced pluripotent stem cells, vascular biology of cancer, mechanisms of thrombosis and novel therapeutic anti-thrombotics. Our post-docs and PhD students are trained in using state-of-the art technologies such as intravital two-photon microscopy, super-resolution microscopy, protein engineering, high throughput small molecule screening or single cell transcriptomics. The training involves acquiring a range of skills from critical thinking and developing an innovative, testable hypothesis to deploying and utilizing relevant methods and technologies. We also offer opportunities to learn how to best communicate ideas and results through presentations and manuscripts. The success of our trainees is evident from their publication records in top tier journals and their current positions in academia and industry.

We have 40 preceptors participating in the training program who exhibit a breadth of scientific expertise ranging from basic cell biology to translational models of vascular disease. The faculty comprises a cohort of exceptionally talented mentors with a commitment to research training, collaboration, and developing careers of young investigators. These trainees and faculty meet regularly at the weekly vascular biology seminar as well as additional departmental seminars with invited speakers, many of whom are renowned leaders in the field of vascular biology. The program has several defining features that:
· contemporary biomedical research training must be underpinned by collaboration that can be local or international,
· research training is driven by fundamental ideas, and
· solving important scientific problems and research training should be such as to provide a variety of opportunities beyond the training phase.
The research training program provides opportunities for exposure to scientific leaders and role models and the intellectual environment of Chicago. It is our view that nurturing curiosity is a fundamental aspect of research training but that it also involves learning to ask important questions and becoming a well-rounded and humane individual.

Co-Director:
Jan Kitajewski, PhD
Email: kitaj@uic.edu

Co-Director:
Kishore Wary, PhD
Email: kkwary@uic.edu

Contact:
Kamil Czarnowski, MPA
Director of Administrative Operations
Physiology and Biophysics
College of Medicine
University of Illinois at Chicago
835 South Wolcott Ave
Room E-231 MSB
Chicago, IL 60612
Phone: 312-996-3836
Email: kczarn4@uic.edu
Web: https://physiology.uic.edu/training/

Program Scope and Mission – The NIH-funded Vascular Biology, Signaling and Therapeutics (VBST) training program is designed to be interdisciplinary, drawing on institutional expertise in four themes: Angiogenesis & Regeneration, Vascular Signaling, Neurovascular Biology and Vascular Therapeutics. VBST is made up of twenty-six (26) mentors, of which nine (9) are physician-scientists. This training program utilizes expertise within and interactions between the themes to train predoctoral and postdoctoral applicants in an integrative fashion.

VBST strives to meet an imperative need to train exceptionally talented and diverse scientists engaged in interdisciplinary vascular research with translational potential. The program’s aims are to assure that trainees understand the human vascular system, and are thereby poised to advance translational opportunities, reduce vascular disease, and bridge the current gaps in knowledge between discovery research, drug development and therapy.

Director and Contact:
Dawood Darbar, MBChB, MD
Email: darbar@uic.edu

Program Scope and Mission – Project Summary Cardiovascular disease (CVD) remains a major cause for significant morbidity and mortality in the U.S. especially in ethnic minorities with their high burden of risk factors. Personalized medicine is a rapidly growing field of healthcare whereby an individual's unique genomic, environmental and clinical background is analyzed to ascertain susceptibility to disease, predict their clinical course and tailor specific therapies. Despite recent advances in CV genomics, our inability to target therapy to underlying mechanisms in individual patients, the failure to translate these scientific discoveries to the bedside care of patients and barriers to the incorporation of ethnic minorities in translational CV research have limited our ability to fulfill the promise of personalized medicine. Furthermore, traditional training programs are no longer able to provide trainees with the requisite skills needed to implement the personalized medicine revolution underway. Thereby, major goals of the Training Program in Personalized Cardiovascular Medicine (TPIPCVM) are to equip trainees to become leaders in CV Genomics and be trained in molecular, cellular, disease and whole animal modeling and clinical and translational approaches to CVD so that this new knowledge can be translated into best evidence-based personalized CV care. We will recruit highly talented and motivated pre- and post-doctoral trainees and provide them with the highest caliber training in CV genomics stemming from existing strengths of our faculty in the Division of Cardiology and our partners at UIC. The 3 Research Focus Groups: 1) Cardiac arrhythmias; 2) Ischemic and non-ischemic cardiomyopathy; and CVD-related metabolic syndrome are highly interrelated with each other and directly linked with the central theme of Personalized CV Genomics. The overarching goal of the TPIPCVM is to train the next generation of CV investigators to create new knowledge and implement into best evidence-based personalized medicine. The TPIPCVM mentors are highly successful physician-scientists/scientists with a proven record of research, mentoring and collaboration who offer superb inter- and multi- disciplinary training opportunities. Major strengths of this training program include: exposure of trainees to an integrated basic science molecular, cellular, and whole patient approach to identify the underlying mechanisms of CVD; the track record of the faculty and their common research interest in Personalized CV Genomics; dedicated training in personalized CV medicine; and the potential to implement scientific discoveries to a diverse and under-represented population of patients cared for at UIC Medical Center. The TPIPCVM sets out to train 2 pre-doctoral and 2 post-doctoral students annually. Collectively, this Training Program offers a unique training experience and fulfills an urgent need for training in personalized CV medicine.

Public Health Relevance

The Training Program In Personalized Cardiovascular Medicine (TPIPCVM) provides support for the training of basic and physician-scientists before and after their doctoral degrees. The central theme of the training program is cardiovascular genomics with a focus on abnormal heart rhythms (arrhythmias), weakened heart muscle (cardiomyopathies) and heart disease related the being overweight (metabolic syndrome) and how we can translate these discoveries to the bedside care of patients. The program will prepare future researchers for the unique challenges associated with treating patients with heart disease in an individualized manner.

Director and Contact:
Martha L. Daviglus, M.D., Ph.D.
Adjunct Professor of Preventive Medicine and Medicine
Executive Director, Institute for Minority Health and Research
Associate Vice Chancellor for Research
Email: daviglus@uic.edu
Phone: 312-413-0739
http://chicago.medicine.uic.edu/research/research-in-chicago/institute-for-minority-health-research/administrative-staff/name/martha-daviglus/
Website: http://chicago.medicine.uic.edu/departments/academic-departments/medicine/research/research-training-programs/

Program Scope and Mission – This Training Program is designed to prepare the next generation of scientists to conduct research in the epidemiology and prevention of cardiovascular disease (CVD) and related chronic diseases in minority populations. Despite decades of research progress, the burden of CVD and related chronic diseases in the United States remains high. Moreover, there are persistent race/ethnic disparities in CVD and other chronic disease outcomes. The goal of this program is to generate a talented and well-trained group of pre- and post-doctoral (MD and PhD) researchers to improve understanding of the etiology and prevention of CVD and related chronic conditions in minority populations and to alleviate race/ethnic disparities in CVD and related chronic disease outcomes.

Director:
Francois M. Abboud, M.D.
Edith King Pearson Chair of Cardiovascular Research
Associate Vice President for Research
Chair Emeritus, Department of Internal Medicine
Founding Director, Francois M. Abboud Cardiovascular Research Center
Professor of Internal Medicine – Cardiovascular Medicine
Professor of Molecular Physiology and Biophysics
Email: Francois-abboud@uiowa.edu
https://medicine.uiowa.edu/internalmedicine/profile/francois-abboud

Contact:
Loretta Bassler
Email: Loretta-bassler@uiowa.edu
Website: https://medicine.uiowa.edu/cardiovascular/research/abboud-cardiovascular-research-center-t-32

Program Scope and Mission – The discovery of the causes of cardiovascular disease and their prevention; the care of the suffering patients and their cure, requires dedicated physicians and scientists to devote their lifelong work to a health mission without which a civilized society would not survive. Such individuals require years of training in medical science beyond their professional degree under the tutelage and mentoring of established senior medical investigators/teachers working in an environment with exceptional intellectual, technical, and physical resources. At the University of Iowa Cardiovascular Research Center, we have provided a world-renowned training center since 1975, have graduated hundreds of scientists, many of whom are national leaders throughout the USA, and aim to continue to do so for future generations with the renewal of federal support that we are applying for and hope to attain.

Contact:
Jordan Shavit, M.D., Ph.D.
Henry and Mala Dorfman Family Professor of Pediatric Hematology/Oncology
Associate Professor of Pediatrics
University of Michigan
jshavit@umich.edu
Website: https://www.shavitlab.org/

Program Scope and Mission – The Boxer Training Program in Molecular and Translational Hematology is designed to prepare physicians and postdoctoral scientists for independent, research-oriented careers in hematology. The program draws on the research interests and expertise of 19 well-funded faculty members in the Departments of Pediatrics, Internal Medicine, Pathology, Pharmacology, Cell and Developmental Biology, Molecular and Integrative Physiology, and Biological Chemistry, the Life Sciences Institute and the Howard Hughes Medical Institute, and the Schools of Engineering and Public Health at the University of Michigan. Active areas include molecular, cellular, and translational research of: 1) the pathophysiology of the immune system; 2) normal and malignant hematopoiesis; 3) hemostasis, thrombosis, and vascular biology; 4) blood and marrow transplantation; and 5) erythrocyte physiology and disease. A Selection/Monitoring Committee will recruit MD, MD/PhD, and PhD trainees with strong academic credentials who desire a scholarly career encompassing hematology teaching and research. MD candidates will have had 3 years of house officer training in Pediatrics or Internal Medicine and a year of clinical training in Pediatric or Adult Hematology/Oncology. PhD candidates will have a major interest in hematology-related research. Trainees spend 2-3 years under supervision of a faculty mentor, developing expertise in posing feasible scientific questions, acquiring skills to answer these questions, and critically evaluating data obtained. During their research training, trainees are continuously mentored and evaluated semiannually by a Mentoring Committee. Trainees present the results of their investigations, participate in discussions of data obtained by their colleagues, and attend relevant research seminars and interact with faculty members in basic and translational sciences. This program will fulfill a critical need to train the next generation of academic hematologists who will bridge the gap between laboratory and clinical research.

Contact:
Daniel Michele, PhD
Professor, Departments of Molecular and Integrative Physiology and Internal Medicine
University of Michigan
North Campus Research Complex
2800 Plymouth Road, Bldg 26, Room 207S
Ann Arbor, MI 48109-2800
Email: dmichele@umich.edu
Website: https://sites.google.com/umich.edu/cvre-t32/home

Program Scope and Mission – Cardiac and vascular diseases remain the leading causes of death worldwide, and the demand for a diversely trained PhD workforce to develop new therapies is expanding. The program goal is to address this deficit in the PhD workforce by teaching the next generation of cardiovascular PhD scientists and engineers how to develop and translate basic research towards applications in clinical medicine. This Predoctoral Training Program includes training on how to conduct preclinical translational research, improve understanding of steps of developing therapies from bench to bedside, and experiential learning in research entrepreneurship. All training is conducted at state of the art facilities of the Frankel Cardiovascular Center laboratories alongside world leading research teams in basic and translational research, clinical research, health services and outcomes research, and multidisciplinary programs.

The Program Features Include:

Basic Cardiovascular Research Training

• Selection of Research Training Mentor & Project and Perform Laboratory Research
• Selection of Clinical Advisor for your Project
• Frontiers in Cardiovascular Sciences Seminar Series
• Research Responsibility and Ethics Training

Training in Pre-Clinical Translational Research

• Pre-clinical Cardiovascular Models, Preclinical Testing and Phenotyping
• Translational Cardiovascular Research Seminars

Training in Research Entrepreneurship

• Research Entrepreneurship Bootcamp
• Entrepreneurship Course
• Experiential Learning in Project Design, Management and Team Science

Fellows are encouraged to explore a variety of additional enrichment activities to supplement the requirements of the training grant.

Director:
Aaron R. Folsom, M.D., M.P.H.
Professor, Division of Epidemiology and Community Health
https://directory.sph.umn.edu/bio/sph-a-z/aaron-folsom

Contact:
Aaron R. Folson, M.D., M.P.H.
1300 S 2nd St
Room 300 West Bank Office Building
Minneapolis, MN 55454
Email: folso001@umn.edu
Website: http://www.sphresearch.umn.edu/epi/cardiovascular-disease-research/

Program Scope and Mission – While the rate of deaths from cardiovascular disease (CVD) has been on the decline, improved survival has resulted in significant new cases and cost to the health care system in our rapidly aging society. Thus the goal of CVD epidemiology is to investigate and promote cardiovascular health, and to prevent and reduce CVD.

Traditionally, cardiovascular disease epidemiology has been concerned with causes of heart disease. In recent years, prevention by modification of lifestyle and behavior have been tested and found very effective. In addition, new methods to detect disease while subclinical have strengthened our studies of antecedent risk factors. Researchers at EpiCH investigate the distribution and causes of CVD and study the influence of:
• high blood cholesterol
• diabetes
• high blood pressure
• blood clotting
• menopause
• genetic variants
• obesity and weight gain
• fat distribution/ patterning They also explore the impact of health behaviors such as:
• smoking
• diet
• physical inactivity
• psychosocial stressors
• education
• geocoding and neighborhoods

Co-Directors:
Prof. Bob Tranquillo
email: tranquillo@umn.edu
and
Prof. Victor Barocas
email: baroc001@umn.edu
website: https://cse.umn.edu/bme/cardiovascular-engineering-training-program

Program Scope and Mission – The proposed T32 training program is designed uniquely to educate, train, and experientially sharpen doctoral students in biomedical engineering, within a multidisciplinary context that specifically engages clinicians and clinician-scientists towards that end. During their participation as trainees in their first two years of predoctoral study in the University of Minnesota (UMN)’s established biomedical engineering graduate program, six trainees per year will interact with a strong training faculty in numerous ways, including these distinctive activities beyond commencing their doctoral research:

• complete the courses Advanced Cardiac Physiology and Anatomy (organized by the leader of UMN-Medtronic Visible Heart Lab collaboration) and Cardiovascular Devices (taught by local cardiovascular device company experts);
• complete a clinical immersion in one of the UMN cardiovascular clinics;
• attend an innovation lecture series (offered through the UMN Medical Devices Center);
• attend monthly clinical focus lunches with invited clinicians presenting specific cardiovascular diseases and associated medical device limitations;
• and attend monthly professional development lunches with invited speakers addressing broad career opportunities including medtech company R&D, FDA, and patent law.

We will recruit a diverse group of trainees, and the program will be reviewed periodically by an advisory committee to ensure its success in all respects. We expect that the resulting multidisciplinary research and perspective of our trainees will enable them to meet the aforementioned demand by driving future technological advancements, either as R&D engineers at cardiovascular device companies, device regulators at federal labs, or as professors leading their own research programs in cardiovascular engineering.

Directors:
Samuel Dudley, MD, PhD
and
Peter Crawford, MD, PhD

Contact:
Elizabeth Gorka
Email: egoldsmi@umn.edu

Program Scope and Mission – This Training Program in Cardiovascular Innovation is designed to teach the scientific and technical skills necessary to develop a novel idea and carry this idea through to proof-of-concept in man. The training program takes unique advantage of the strengths of the Lillehei Heart Institute (LHI), the University of Minnesota Cardiovascular Division, the wider community of translational medicine and entrepreneurship at the University of Minnesota, and the Twin Cities biotech, pharma, and device industries. This application trains basic and clinical scientists in an interdisciplinary environment with the goal of giving them the insight and tools to be able to successfully carry an idea from conception to implementation in man. Therefore, the major goal of this new Training Program is to provide an interdisciplinary research and training environment wherein trainees will be exposed to the continuum of technological development from conceptual idea to testing at the basic, small animal, large animal, and human levels. Trainees will be advantaged by community strengths in basic, translational, and clinical science, training in cardiovascular innovation and entrepreneurship, and industry interactions and mentorship. The combination of scientific and entrepreneurship training is the central innovative feature of this application.

Contact:
John Spertus, MD, MPH
Missouri/Lauer Endowed Chair
Professor, University of Missouri-Kansas City
Clinical Director, Outcomes Research
Saint Luke’s Mid America Heart Institute
MAHIResearch@saintlukesks.org
https://www.saintlukeshealthsystem.org/cardiovascular-outcomes-research-postdoctoral-fellowship

Program Scope and Mission – Applications are invited for a 2-year postdoctoral training program in cardiovascular outcomes research to begin July 1, 2018. This T32 training program, funded by the National Heart Lung and Blood Institute to the University of Missouri-Kansas City (UMKC), is hosted by Saint Luke’s Mid America Heart Institute (SLMAHI) in close collaboration with the University of Kansas.

The Full-Time Training Program offers:
• Advanced seminars of specialized skills for Outcomes Research
• Opportunity to obtain an MS in Bioinformatics with an emphasis in Clinical Research for those without prior formal training in the field
• Multidisciplinary mentorship, individualized to meet the needs of each Fellow
• Hands-on research experiences with access to highly experienced statisticians and numerous databases including multicenter outcome registries (e.g., PREMIER, TRIUMPH, PORTRAIT, PRISM, OPEN CTO, OPTIMUM), clinical trial databases (e.g., PARTNER, FREEDOM, SYNTAX), national quality databases (e.g., ACC’s National Cardiovascular Data Registries, AHA’s National Registry of Cardiopulmonary Resuscitation) and publically available clinical trial and observational data sets.
• Salaried position based on NIH postdoctoral stipend scales
• Insurance benefits, vacation time, tuition (for MS coursework), and funds for travel expenses to professional conference(s)

Director:
Jon Matsumura, MD
Email: tomatsumura@surgery.wisc.edu

Contact:
Sarah Pavao, Program Coordinator
Associate Administrative Program Specialist
Department of Surgery | University of Wisconsin School of Medicine and Public Health
K6/160 CSC | 600 Highland Avenue | Madison, WI 53792-1690
Phone: 608.262.0744
Fax: 608.252.0919
E-mail: pavao@surgery.wisc.edu
http://www.surgery.wisc.edu/education-training/training-for-researchers/uw-vascular-surgery-research-training-program/

Program Scope and Mission – The University of Wisconsin Vascular Surgery Research Training Program is a multidisciplinary and collaborative program that will co-train young physician/surgeons who have chosen to be vascular specialists, along with PhD scientists who have a research interest in vascular disease. This NIH-funded program provides trainees with multiple opportunities for research activities in vascular-related research disciplines in order to foster the development of knowledge, skill, and experience for success in the future academic careers of our trainees. Our goal is to accelerate the performance of basic, translational and clinical research for vascular disease by producing future surgeons, scientists and engineers who will meet the great need for innovation in treatments for the growing population of patients.

Director:
Dr. Anjon Audhya
Molecular and Cellular Pharmacology
School of Medicine and Public Health
5214a Biochemistry
420 Henry Mall
Madison, WI 53706
Phone: (608) 262-3761
Email: audhya@wisc.edu

Contact:
Kristin Cooper, MS
Program Coordinator
Molecular and Cellular Pharmacology
University of Wisconsin-Madison
Mail: Room 1005, 1111 Highland Ave
Office: L5/175
Madison, WI 53705
Phone: (608) 262-9826
Email: kgcooper@wisc.edu
http://molpharm.wisc.edu/

Program Scope and Mission – Pharmacology is the knowledge of the biochemical and physiological actions of drugs, which act on cellular signaling pathways. The molecular basis of cellular signaling and its control by various drugs is a major aspect of modern pharmacology and this aspect is emphasized in the Molecular and Cellular Pharmacology Training Program. The majority of signal transduction pathways still await discovery or at least a thorough molecular characterization. Members of our program employ the whole spectrum of modern biochemical, cell and molecular biological, physiological, and pharmacological methods in a basic research-oriented scientific environment to unravel the many unsolved mysteries underlying cellular regulation and signaling. Certain research initiatives have a translational component, with the goal of applying basic discoveries to developing new therapeutic modalities.
Our program brings together an outstanding group of over 70 dedicated trainers with a focus on cellular signal transduction. Graduates of the program will be well prepared for a career in basic biomedical sciences in academia, industry, and more. We provide a unique training experience for young scientists who want to elucidate basic principles of cellular signal pathways. Detailed knowledge of these pathways is the most important prerequisite for the discovery of new drugs and the treatment of diseases. The members of the Molecular and Cellular Pharmacology Training Program invite you to examine the educational and research opportunities described on our website, and to consider joining this unique and exciting graduate program.

Director:
Jian-Ping Jin, M.D., Ph.D.
Professor & William D. Traitel Endowed Chair
Wayne state University School of Medicine
Department of Physiology
Email: jjin@med.wayne.edu

Contact:
Christine R. Cupps
Program Administrator
Detroit Cardiovascular Training Program
Wayne State University
Department of Physiology
5278 Scott Hall
540 E. Canfield
Detroit, MI 48201
Phone: 313-577-4639
Email: ccupps@med.wayne.edu
Website: http://physiology.med.wayne.edu/dctp

Program Scope and Mission – Cardiovascular disease is a leading cause of mortality in the United States. Understanding the physiology and pathology of the heart and circulation is the foundation for improving the treatment and prevention of cardiovascular diseases. The Detroit Cardiovascular Training Program (DCTP) was the first NIH-supported predoctoral training program in the region to provide research training for PhD graduate students in integrative and translational cardiovascular sciences. This training effort is contributing to the education of a new generation of scientists who will not only pursue cardiovascular research to improve health care, but also strengthen our economic base by innovations that will be translated to medical practice.

The DCTP has assembled an leading group of researchers from multiple departments such has Physiology, Biomedical Engineering, and Pharmaceutical Sciences, who provide expertise and research opportunities to trainees that range from molecular, cellular and organ levels to clinic research. In addition, Wayne State University has an outstanding track record of providing extensive training in the cardiovascular sciences and an exceptional record in the training of minority students in the Detroit metropolitan area, contributing a major role in research education in the region.

Director and Contact:
Jeanne M. Nerbonne, Ph.D.
Email: jnerbonne@wustl.edu
Website: https;//integrativesystemsbiologytraining.wustl.edu

Program Scope and Mission – The goals of the Integrative and Systems Biology of Cardiovascular Disease Training Program in the Center for Cardiovascular Research at Washington University are to provide predoctoral and postdoctoral trainees with: outstanding research opportunities; fundamental education and basic training in cardiovascular physiology, pathophysiology and disease mechanisms; opportunities to be introduced to and to participate in, translational cardiovascular research; and, mentoring to prepare them to be productive, independent scientists, educators and mentors. The critical components and the clear strengths of this Program are the twenty-one (23) participating faculty and the trainees themselves. Another clear strength of this Training Program is the highly interactive and collaborative environment in the Center for Cardiovascular Research, indeed at Washington University in general, which translates to expanded research, education, training and mentoring opportunities for all of our trainees. The participating training faculty derive from seven Departments, and includes nationally and internationally recognized leaders in the three research and training areas of emphasis in this Training Program: 1) Cardiac biology, remodeling and cardiomyopathies; 2) Ion channels, myocardial excitability and arrhythmias; and, 3) Vascular biology, inflammation and coronary disease. The participating faculty are all highly interactive, collaborative, productive, well-funded investigators who are committed to providing the training, experience, resources, intellectual enthusiasm, and mentoring needed to facilitate the scientific and professional development of the Program trainees. In addition, trainees in this Program participate in: a “Core Curriculum in Integrative and Systems Cardiovascular Biology”, with an continuing emphasis on Rigor and Reproducibility and the Responsible Conduct of Research; weekly "Trainees in Cardiovascular Biology" work in progress series; weekly “Cardiovascular Research” seminar series; biannual “Cardiovascular Training Program Distinguished Lectureship”; and “Cardiovascular Research Day”. This Training Program also provides trainees the opportunity to participate in translational cardiovascular research, and has developed and implemented formal and informal mechanisms to guide trainees in the formulation of individualized educational, training and career development plans and for monitoring the progress, professional development and mentoring of each predoctoral and postdoctoral trainee. Formal mechanisms are also in place for evaluating, and evolving as needed, the Training Program itself.

Simply send a description of your program to sharon@navbo.org. Include contact information and links to your web site.